Thromb Haemost 2004; 91(06): 1223-1231
DOI: 10.1160/TH03-07-0456
New Technologies and Diagnostic Tools
Schattauer GmbH

INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples

Tomas L. Lindahl
1   Departments of Clinical Chemistry, University Hospital of Linköping, Linköping, Sweden
,
Nils Egberg
2   Karolinska Hospital, Stockholm, Sweden
,
Andreas Hillarp
3   Malmö University Hospital, Malmö, Sweden
,
Ole R. Ødegaard
4   Aker University Hospital, Oslo, Norway
,
Bror Edlund
5   Örebro University Hospital, Örebro, Sweden
,
Jan Svensson
2   Karolinska Hospital, Stockholm, Sweden
,
Per M. Sandset
6   Department of Hematology, Ullevål University Hospital, Oslo, Norway
,
Mats Rånby
1   Departments of Clinical Chemistry, University Hospital of Linköping, Linköping, Sweden
› Author Affiliations
Further Information

Publication History

Received 11 July 2003

Accepted after revision 15 March 2004

Publication Date:
02 December 2017 (online)

Summary

Prothrombin time (PT) is clinically important and is used to monitor oral anticoagulant therapy. To obtain PT results in international normalized ratio (INR), the current standardization procedure is complex and involves reference reagents.The PT of diluted plasma samples can be determined with a combined thromboplastin (the Owren-type procedure), but not necessarily with a plain thromboplastin (the Quick-type procedure). Owren-type PT procedures can therefore, as an alternative to the INR calibration, be calibrated with diluted normal plasma to give PT results in percent of normal PT activity (PT%).The present study explored if a plasma-based calibration of an Owren-type PT procedure can be used to obtain results in INR. The approach was to establish a relationship between PT% and INR by multi-center analysis of 365 samples from healthy individuals and patients on warfarin treatment. INR values were obtained by manual Quick-type reference procedure and PT% values by various automated Owren-type procedures. A relationship INR = (1/PT% + 0.018)/0.028 was found. A calibration procedure, based on the relationship, was investigated. Calibrators were the median PT of 21 normal plasma at dilutions representing 100%, 50%, 25%, 12.5% and 6.25% of normal PT activity. These were assigned INR values of 1.00, 1.36, 2.07, 3.05 and 6.36. Calibration of various Owren-type assays was repeatedly performed by 5 expert laboratories during 3 consecutive years. The INR values of certain lyophilised or frozen control plasmas were determined. The frozen control plasmas had externally assigned INR values according to WHO guidelines. Within the laboratory, CV was typically below 3%. No appreciable difference among the results of the different laboratories or the three assay occasions was found. Externally assigned and INR values were essentially identical to those found. These and other results indicated that the calibration procedure was reproducible, precise and accurate. Thus, an Owren-type PT assay can be calibrated with normal plasma samples to give results in INR and the investigated calibration procedure can be proposed for this purpose.

 
  • References

  • 1 Quick A, Stanley-Brown M, Bancroft F. A study of the coagulation defect in hemophilia and jaundice. Am J Med Sci 1935; 190: 501-11.
  • 2 Quick A. The prothrombin time in hemophilia and in obstructive jaundice. J Biol Chem 1935; 109: 73-4.
  • 3 Owren P, Aas K. The control of Dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand J Clin Lab Invest 1951; 03: 201-8.
  • 4 Owren P. Thrombotest A new method for controlling anticoagulant therapy. Lancet 1959; 02: 754-8.
  • 5 Kitchen S, Jennings I, Woods TA. et al. Two recombinant tissue factor reagents compared to conventional thromboplastins for determination of international normalised ratio: a thirty-three-laboratory collaborative study The Steering Committee of the UK National External Quality Assessment Scheme for Blood Coagulation. Thromb Haemost 1996; 76: 372-6.
  • 6 Poller L, Hirsch J. Laboratory monitoring of anticoagulants. In: Oral anticoagulants. Poller L, Hirsch J. eds London: Arnold; 1996: 49-64.
  • 7 Gogstad G. The reporting of thrombotest in international normalized ratio (INR). Farmakoterapi 1984; 40: 88-92.
  • 8 Hillarp A, Egberg N, Nordin G. et al. Local INR calibration of the Owren-type prothrombin assay greatly improves the intraand interlaboratory variationA three-year follow-up from the Swedish national external quality assessment scheme. Thromb Haemost 2004; 91: 300-7.
  • 9 van den Besselaar AM. Multi-center study of replacement of the international reference preparation for thromboplastin, rabbit, plain. Thromb Haemost 1993; 70: 794-9.
  • 10 Poller L, Barrowcliffe TW, van den Besselaar AM. et al. European Concerted Action on Anticoagulation (ECAA)-the multicentre calibration of rabbit and human ECAA reference thromboplastins Steering Committee. Thromb Haemost 1996; 76: 977-82.
  • 11 van den Besselaar AM. International normalized ratio: towards improved accuracy. Thromb Haemost 1999; 82: 1562-3.
  • 12 Poller L. The prothrombin time. WHO/LAB 1998; 98 3: 1-32.
  • 13 Horsti J. Has the Quick or the Owren prothrombin time method the advantage in harmonization for the International Normalized Ratio system?. Blood Coagul Fibrinolysis 2002; 13: 641-6.
  • 14 van den Besselaar AM, HoubouyanReveillard LL, Aillaud MF. et al. Multicenter evaluation of lyophilized and deep-frozen plasmas for assignment of the International Normalized Ratio. Thromb Haemost 1999; 82: 1451-5.
  • 15 Stevenson KJ, Craig S, Dufty JM. et al. System ISI calibration: a universally applicable scheme is possible only when coumarin plasma calibrants are used. Br J Haematol 1997; 96: 435-41.
  • 16 Heuck CC, Magrath D. The role of WHO and international organizations in promoting international standardization. Eur J Clin Chem Clin Biochem 1995; 33: 989-92.